\-\ Texto\\:\\ \ \(0\)\
\-\ palpable\\ left\\ axillary\\ adenopathy\\.\ \(0\)\
\-\ asymmetric\\ skin\\ and\\ trabecular\\ thickening\\ and\\ a\\ solid\\ mass\\ at\\ the\\ 6\\:00\\ position\\ of\\ the\\ affected\\ breast\\ with\\ associated\\ axillary\\ adenopathy\\.\ \(0\)\
\-\ inflammatory\\ breast\\ carcinoma\ \(0\)\
\-\ metastatic\\ disease\\,\\ lymphoma\\,\\ mastitis\\ with\\ focal\\ phlegmonous\\ inflammation\\ \\(not\\ yet\\ an\\ abscess\\)\ \(0\)\
\-\ 48\\ yo\\ woman\\ with\\ palpable\\ abnormality\\ 5\\:00\\-6\\:00\\ position\\ of\\ left\\ breast\\ with\\ signs\\ of\\ breast\\ edema\\ on\\ recent\\ screening\\ exam\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ breast\\:\\ 0\\.40978730569705946\ \(0\)\
\-\ axillary\\:\\ 0\\.2775368544352918\ \(0\)\
\-\ adenopathy\\:\\ 0\\.23734367371190004\ \(0\)\
\-\ position\\:\\ 0\\.22494926290216205\ \(0\)\
\-\ palpable\\:\\ 0\\.19822505990102315\ \(0\)\
\-\ phlegmonous\\:\\ 0\\.19463175493084992\ \(0\)\
\-\ mastitis\\:\\ 0\\.18581060922868\ \(0\)\
\-\ trabecular\\:\\ 0\\.15947859824422403\ \(0\)\
\-\ yet\\:\\ 0\\.14276607812586262\ \(0\)\
\-\ asymmetric\\:\\ 0\\.12696060164922132\ \(0\)\
\-\ 48\\:\\ 0\\.12218576620707627\ \(0\)\
\-\ affected\\:\\ 0\\.11603336622078135\ \(0\)\
\-\ screening\\:\\ 0\\.11460339512829303\ \(0\)\
\-\ inflammation\\:\\ 0\\.1133835068061355\ \(0\)\
\-\ with\\:\\ 0\\.11049942566992102\ \(0\)\
\-\ solid\\:\\ 0\\.10815749265765613\ \(0\)\
\-\ skin\\:\\ 0\\.10494890451419663\ \(0\)\
\-\ abnormality\\:\\ 0\\.10261738992966475\ \(0\)\
\-\ signs\\:\\ 0\\.09859803510583165\ \(0\)\
\-\ left\\:\\ 0\\.09624963608850999\ \(0\)\
\-\ thickening\\:\\ 0\\.09597775616714904\ \(0\)\
\-\ recent\\:\\ 0\\.09552395242104322\ \(0\)\
\-\ inflammatory\\:\\ 0\\.09539580907603094\ \(0\)\
\-\ abscess\\:\\ 0\\.09059025930867444\ \(0\)\
\-\ yo\\:\\ 0\\.0881375961268474\ \(0\)\
\-\ carcinoma\\:\\ 0\\.08438654501432381\ \(0\)\
\-\ focal\\:\\ 0\\.08438654501432381\ \(0\)\
\-\ edema\\:\\ 0\\.08414207900149365\ \(0\)\
\-\ lymphoma\\:\\ 0\\.08402074624664993\ \(0\)\
\-\ of\\:\\ 0\\.08282508128610844\ \(0\)\
\-\ metastatic\\:\\ 0\\.07737428249325388\ \(0\)\
\-\ associated\\:\\ 0\\.07435873998750765\ \(0\)\
\-\ woman\\:\\ 0\\.07347393761627287\ \(0\)\
\-\ exam\\:\\ 0\\.07101878790451367\ \(0\)\
\-\ disease\\:\\ 0\\.059219576043516964\ \(0\)\
\-\ and\\:\\ 0\\.05830412578278271\ \(0\)\
\-\ the\\:\\ 0\\.056300387164260085\ \(0\)\
\-\ not\\:\\ 0\\.05569427939621949\ \(0\)\
\-\ an\\:\\ 0\\.053947793246539\ \(0\)\
\-\ mass\\:\\ 0\\.053888069454516595\ \(0\)\
\-\ at\\:\\ 0\\.05328698572310827\ \(0\)\
\-\ on\\:\\ 0\\.04260800884725175\ \(0\)\
